Protropin: A Game Changer in Treating Growth Hormone Deficiency
Protropin, developed in the 1980s by Genentech, is a bioengineered human growth hormone crucial for treating growth hormone deficiencies, especially in children with such disorders. This recombinant hormone replaced earlier treatments that used somatotropin from human pituitary glands, reducing contamination risks. Although initially groundbreaking, Protropin has been largely replaced by newer formulations identical to natural growth hormone, offering better efficacy and safety in modern medical practice.

